BioWorld

May 3, 2001

View Archived Issues

Rejuvenon Completes $12M Round For Aging Treatments

Read More

Connetics Sells Ridaura Rights, Pulls Out of Rheumatology

Read More

Other News To Note

Read More

Genicon Raises $27M For Resonance Light Scattering

Read More

Genzyme Plans $500M Sale Of Notes, Calls 1998 Notes

Read More

Weaponized Anthrax Toxin, Tamed By Mutagenizing Virulence Factor, Saves Rats From Death In Minutes

Read More

Cephalon Placement Raises $300M In Convertible Notes

Read More